Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Jan 27, 2024; 16(1): 124-133
Published online Jan 27, 2024. doi: 10.4240/wjgs.v16.i1.124
Table 2 Baseline data of patients after propensity score matching
Data
Control group (n = 30)
Observation group (n = 30)
t/χ2/Z
P value
Age (year, mean ± SD)54.97 ± 7.5454.83 ± 11.520.0530.958
Sex, n (%)0.0670.795
        Male17 (56.67)16 (53.33)
        Female13 (43.33)14 (46.67)
BMI (kg/m2, mean ± SD)22.11 ± 1.5422.01 ± 1.620.2370.814
Underlying disease, n (%)
        Hypertension7 (23.33)10 (33.33)0.7390.390
        Diabetes10 (33.33)5 (16.67)2.2220.136
        CHD7 (23.33)4 (13.33)0.4450.505
Tumor diameter (cm, mean ± SD)3.86 ± 0.483.81 ± 0.560.3470.730
TNM stage, n (%)0.7010.483
        I15 (50.00)17 (56.67)
        II12 (40.00)12 (40.00)
        III3 (10.00)1 (3.33)
Histological type, n (%)0.8420839
        Adenocarcinoma11 (36.67)13 (43.33)
        Mucinous adenocarcinoma10 (33.33)7 (23.33)
        Squamous cell carcinoma6 (20.00)6 (20.00)
        Other3 (10.00)4 (13.33)
Tumor location, n (%)4.1490.246
        Rectum12 (40.00)17 (56.67)
        Descending colon9 (30.00)3 (10.00)
        Ascending colon6 (20.00)6 (20.00)
        Sigmoid flexure3 (10.00)4 (13.33)
ASA grade, n (%)0.0080.994
        I12 (40.00)10 (33.33)
        II10 (33.33)15 (50.00)
        III5 (16.67)2 (6.67)
        IV3 (10.00)3 (10.00)